Latest News
The center will have an ambitious goal: to produce better diagnoses, treatments, and ultimately cures for an array of diseases. It will also work toward vaccine development, based on Iwasaki’s pioneering work showing that vaccines directed toward the mucosa might provide better protection than systemic vaccination.
- April 11, 2022
Dr. Akiko Iwasaki’s efforts to create a nasal spray vaccine that generates an effective immune response to COVID-19 evolved from work first sponsored by Women’s Health Research at Yale almost two decades ago.
- March 11, 2022Source: Next Question with Katie Couric
On this episode of Next Question with Katie Couric, Katie unpacks the systemic issues that are impeding patients’ care and conveys the urgent needs of the long COVID community to elected officials.
- March 10, 2022Source: Next Question with Katie Couric
On this episode of Next Question with Katie Couric — part 1 of a two-part series — Katie attempts to understand long COVID — what it is, what it can do to the body, who is affected, and how it is upending lives.
- February 25, 2022
A Sterling Professorship is considered the highest academic honor a Yale professor can receive.
- February 15, 2022
The Howard Hughes Medical Institute (HHMI) has provided $10 million to HHMI Investigators at Yale, an HHMI host institution. The funding supports collaborative research projects through the labs of some of the leading experts at the forefront of COVID-19 research.
- February 14, 2022
A Yale research team led by Akiko Iwasaki, PhD, has found success in a new approach to vaccination—systemic vaccines that train the entire body’s immune response followed by boosters administered directly to the nasal cavity, to deliver special protection in the part of the body most affected by SARS-CoV-2 infection.
- February 09, 2022
A new study by Yale researchers provides a single-cell resolution profile of the inflammatory severe COVID-19 disease, and the loss of coordination between the innate and adaptive immune response. This loss of coordination has the potential to amplify a person’s immune response to COVID-19, delaying viral clearance.
- February 02, 2022Source: The New York Times
Nasal vaccines under development around the world may make better boosters by stopping the coronavirus in the airways.
- January 26, 2022
In search of answers about long COVID-19, scientists turn to social media.